BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16549273)

  • 1. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study.
    Tabarés-Seisdedos R; Escámez T; Martínez-Giménez JA; Balanzá V; Salazar J; Selva G; Rubio C; Vieta E; Geijó-Barrientos E; Martínez-Arán A; Reiner O; Martínez S
    Neuroscience; 2006; 139(4):1289-300. PubMed ID: 16549273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from a Spanish isolate population.
    Tabarés-Seisdedos R; Mata I; Escámez T; Vieta E; López-Ilundain JM; Salazar J; Selva G; Balanzá V; Rubio C; Martínez-Arán A; Valdés-Sánchez L; Geijo-Barrientos E; Martínez S
    Psychiatr Genet; 2008 Dec; 18(6):313-7. PubMed ID: 19018238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanism of lissencephaly--how LIS1 and NDEL1 regulate cytoplasmic dynein?].
    Hirotsune S
    Brain Nerve; 2008 Apr; 60(4):375-81. PubMed ID: 18421979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location and type of mutation in the LIS1 gene do not predict phenotypic severity.
    Uyanik G; Morris-Rosendahl DJ; Stiegler J; Klapecki J; Gross C; Berman Y; Martin P; Dey L; Spranger S; Korenke GC; Schreyer I; Hertzberg C; Neumann TE; Burkart P; Spaich C; Meng M; Holthausen H; Adès L; Seidel J; Mangold E; Buyse G; Meinecke P; Schara U; Zeschnigk C; Muller D; Helland G; Schulze B; Wright ML; Kortge-Jung S; Hehr A; Bogdahn U; Schuierer G; Kohlhase J; Aigner L; Wolff G; Hehr U; Winkler J
    Neurology; 2007 Jul; 69(5):442-7. PubMed ID: 17664403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does subtle disturbance of neuronal migration contribute to schizophrenia and other neurodevelopmental disorders? Potential genetic mechanisms with possible treatment implications.
    Deutsch SI; Burket JA; Katz E
    Eur Neuropsychopharmacol; 2010 May; 20(5):281-7. PubMed ID: 20207112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of genomic deletions--and a duplication--in the LIS1 gene in lissencephaly: implications for molecular diagnosis.
    Mei D; Lewis R; Parrini E; Lazarou LP; Marini C; Pilz DT; Guerrini R
    J Med Genet; 2008 Jun; 45(6):355-61. PubMed ID: 18285425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia.
    Rybakowski JK; Borkowska A; Skibinska M; Hauser J
    Psychiatr Genet; 2007 Jun; 17(3):201-4. PubMed ID: 17417065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mechanisms underlying abnormal neuronal migration in classical lissencephaly.
    Kerjan G; Gleeson JG
    Trends Genet; 2007 Dec; 23(12):623-30. PubMed ID: 17997185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lissencephaly and LIS1: insights into the molecular mechanisms of neuronal migration and development.
    Wynshaw-Boris A
    Clin Genet; 2007 Oct; 72(4):296-304. PubMed ID: 17850624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIS1-related isolated lissencephaly: spectrum of mutations and relationships with malformation severity.
    Saillour Y; Carion N; Quelin C; Leger PL; Boddaert N; Elie C; Toutain A; Mercier S; Barthez MA; Milh M; Joriot S; des Portes V; Philip N; Broglin D; Roubertie A; Pitelet G; Moutard ML; Pinard JM; Cances C; Kaminska A; Chelly J; Beldjord C; Bahi-Buisson N
    Arch Neurol; 2009 Aug; 66(8):1007-15. PubMed ID: 19667223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence for mitochondrial dysfunction in bipolar disorder.
    Konradi C; Eaton M; MacDonald ML; Walsh J; Benes FM; Heckers S
    Arch Gen Psychiatry; 2004 Mar; 61(3):300-8. PubMed ID: 14993118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET).
    Rybakowski JK; Borkowska A; Czerski PM; Dmitrzak-Weglarz M; Skibinska M; Kapelski P; Hauser J
    Psychiatry Res; 2006 Jun; 143(1):13-9. PubMed ID: 16712949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder.
    Frangou S; Haldane M; Roddy D; Kumari V
    Biol Psychiatry; 2005 Nov; 58(10):838-9. PubMed ID: 16043135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of 17p13 and LIS1 gene mutation in isolated lissencephaly sequence.
    Elias RC; Galera MF; Schnabel B; Briones MR; Borri ML; Lipay M; Carvalheira G; Brunoni D; Melaragno MI
    Pediatr Neurol; 2006 Jul; 35(1):42-6. PubMed ID: 16814084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar I patients with and without a history of psychotic symptoms: do they differ in their cognitive functioning?
    Selva G; Salazar J; Balanzá-Martínez V; Martínez-Arán A; Rubio C; Daban C; Sánchez-Moreno J; Vieta E; Tabarés-Seisdedos R
    J Psychiatr Res; 2007; 41(3-4):265-72. PubMed ID: 16762369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder.
    Anitha A; Nakamura K; Yamada K; Iwayama Y; Toyota T; Takei N; Iwata Y; Suzuki K; Sekine Y; Matsuzaki H; Kawai M; Miyoshi K; Katayama T; Matsuzaki S; Baba K; Honda A; Hattori T; Shimizu S; Kumamoto N; Tohyama M; Yoshikawa T; Mori N
    Biol Psychiatry; 2008 Apr; 63(7):678-85. PubMed ID: 17884020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia.
    Takizawa R; Hashimoto K; Tochigi M; Kawakubo Y; Marumo K; Sasaki T; Fukuda M; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):491-8. PubMed ID: 19439245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.